Menu Search
Equities

Biotechnology Assets SA

041:STU

Biotechnology Assets SA

Actions
  • Price (EUR)0.2385
  • Today's Change0.004 / 1.49%
  • Shares traded0.00
  • 1 Year change-21.29%
  • Beta--
Data delayed at least 15 minutes, as of Jun 25 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biotechnology Assets SA, formerly known as ADL Bionatur Solutions SA, is a Spain-based biotech company. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

  • Revenue in EUR (TTM)3.60m
  • Net income in EUR1.57m
  • Incorporated2005
  • Employees37.00
  • Location
    Biotechnology Assets SAAv. del Desarrollo Tecnologico, 11JEREZ DE LA FRONTERA 11591SpainESP
  • Phone+34 856818424
  • Fax+34 956876851
  • Websitehttps://biatgroup.com/es/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.